Open AccessThe reason for regimen change among HIV/AIDS patients initiated on first line highly active antiretroviral therapy in Southern Ethiopia
Author(s) -
Beharu Woldemedhin,
Nasir Wabe
Publication year - 2012
Publication title -
north american journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2250-1541
pISSN - 1947-2714
DOI - 10.4103/1947-2714.92898
Subject(s) - medicine , regimen , stavudine , nevirapine , lamivudine , efavirenz , zidovudine , population , pregnancy , comorbidity , viral load , pediatrics , antiretroviral therapy , immunology , human immunodeficiency virus (hiv) , viral disease , genetics , hepatitis b virus , virus , environmental health , biology
Highly active antiretroviral therapy (HAART) has markedly decreased the morbidity and mortality due to HIV disease. However, toxicities, comorbidity, pregnancy, and treatment failure, among others, would result in frequent initial HAART regimen change.